SOC2 + HIPAA BAA LLM observability platform with SSO/SAML and EU data residency

Most teams evaluating an LLM observability platform today have a clear non‑negotiable checklist: SOC 2, a HIPAA BAA, SSO/SAML, and EU data residency options—without giving up deep tracing and evaluation. The challenge is finding something that can actually ship production AI agents, not just log a few prompts for demos, while still satisfying security and compliance.

Quick Answer: Arize provides an AI & agent engineering platform with SOC 2 Type II and HIPAA compliance, supports HIPAA BAAs, offers SSO/SAML (including Okta and AzureAD/EntraID) with space‑level RBAC, and can keep LLM observability data in EU regions. It combines these controls with production‑grade LLM tracing, evaluation, and monitoring so you don’t have to trade away security to get real observability.

Why This Matters

If you’re running LLMs or agents on regulated or sensitive data—healthcare, financial services, HR, trust & safety—you don’t just need observability; you need observability that passes audit. That means:

• Clear security and compliance posture (SOC2 + HIPAA + BAA).
• Strong identity and access controls (SSO/SAML with granular RBAC).
• Regional data residency (EU‑only or EU‑preferred storage).
• Transparent, open‑standard instrumentation so you can prove what’s logged and how it flows.

Without this, you end up with shadow tooling: ad‑hoc logs on engineers’ laptops, screenshots in Slack, or black‑box “AI monitoring” that compliance teams can’t sign off on. A platform like Arize is built to close that gap so you can instrument every span and still meet your SLOs, data residency rules, and audit requirements.

Key Benefits:

• Production‑grade compliance: SOC 2 Type II, HIPAA compliance, and HIPAA BAA support so LLM traces and evals can safely include PHI or other sensitive data.
• Enterprise identity & access control: SSO/SAML with Okta, AzureAD/EntraID and space‑level RBAC so each team sees only what they should.
• Regional data residency: EU (and other region) deployment options and self‑hosting add‑ons to keep observability data where your regulators expect it, without losing tracing fidelity.

Core Concepts & Key Points

Concept	Definition	Why it's important
SOC2 + HIPAA LLM observability	An observability platform for LLMs and agents that meets SOC 2 Type II and HIPAA standards, including support for Business Associate Agreements (BAAs).	Lets you trace and evaluate AI systems that touch PHI or other regulated data without building a separate, reduced‑fidelity pipeline.
SSO/SAML with RBAC	Single sign‑on via enterprise identity providers (e.g., Okta, AzureAD/EntraID) using SAML/OIDC, combined with organization and space‑level role‑based access control.	Centralizes access, enforces least privilege, and gives auditability for who saw which spans, traces, and datasets.
EU data residency for LLM traces	Hosting and data storage options that keep LLM logs, traces, and evaluations in EU regions (or other required jurisdictions).	Satisfies data sovereignty rules and internal policies while maintaining full‑fidelity tracing, not just redacted aggregates.

How It Works (Step-by-Step)

One platform. Open standards. Compliance‑ready by design.

Below is how a SOC2 + HIPAA‑grade LLM observability stack typically comes together with Arize.

1. Establish secure identity & access (SSO/SAML + RBAC)

   • Connect Arize to your identity provider (IdP) such as Okta, AzureAD/EntraID, or other SAML/OIDC providers.
   • Enforce SSO so all users authenticate through your IdP—no separate passwords, no unmanaged accounts.
   • Define organization‑wide roles and space‑level RBAC:
     • Separate spaces for production vs. sandbox vs. vendor environments.
     • Restrict PHI‑touching projects to specific security groups.
   • Use service accounts for CI/CD, agents, and background jobs, keeping human and machine identities cleanly separated.

2. Select data region and residency model (EU and beyond)

   • Choose the appropriate data region for your organization (e.g., EU) so logs, spans, and evaluations stay within jurisdictional boundaries.
   • For stricter requirements, use the self‑hosting add‑on and multi‑region deployments:
     • Deploy Arize closer to where data is generated.
     • Control data residency at the infrastructure layer while keeping the same observability UX.
   • Configure data retention policies to meet your internal and regulatory timelines—only keep as long as needed for debugging, audits, and model improvement.

3. Instrument AI systems with open standards (OTEL + OpenInference)

   • Standardize on OpenTelemetry (OTEL) for tracing and OpenInference‑style conventions so every request, tool call, and model interaction is a span.
   • Capture:
     • Prompt, parameters, and model metadata.
     • Tool calls with input/output schemas.
     • RAG/retriever calls with document IDs and scores.
     • Multi‑agent interactions as full traces, not siloed logs.
   • Use Arize Phoenix (self‑hosted open source) for local/secure tracing and evaluation, and Arize AX for integrated development + evaluation + observability when you’re ready.

4. Apply evaluation and guardrails (LLM as a Judge + code evals)

   • Configure offline and online evaluations for:
     • Hallucination risk and answer correctness.
     • Tool selection and parameter extraction quality.
     • Safety and policy violations (PII/PHI leaks, disallowed topics).
   • Use LLM‑as‑a‑Judge templates, open‑source evaluators, and deterministic code evals so nothing is a black box.
   • Queue flagged spans into annotation queues for human review, creating golden datasets for regression tests.

5. Monitor, alert, and audit (dashboards, logs, and reports)

   • Build dashboards and widgets around key slices: by region, tenant, line of business, or PHI exposure risk.
   • Set alerts on custom metrics like hallucination rate, tool‑error rate, and safety‑eval failures.
   • Use audit logs to see who accessed what:
     • User login history via SSO.
     • Changes to experiments, prompts, and eval configs.
     • Dataset exports and API usage.
   • Leverage SOC2 Type II and HIPAA compliance reports during audits to show that your observability platform meets required controls.

6. Gate deployments with evaluation‑driven CI/CD

   • Treat prompts, policies, and routing logic like code:
     • Every change becomes an experiment.
     • Compare against a baseline with evals and golden datasets.
   • Use CI/CD experiments and online evals to block regressions before they hit production.
   • Automatically feed production edge cases back into datasets and experiments—closing the loop between development and production.

Common Mistakes to Avoid

• Treating observability as ‘non‑sensitive’ data:
  LLM logs can contain PHI, PII, or regulated business data even if you never intended them to. Avoid shipping traces to generic logging tools that aren’t SOC2/HIPAA‑ready. Use a platform that explicitly supports HIPAA and BAAs for LLM observability.

• Relying on proprietary, black‑box tracing frameworks:
  Custom or closed tracing formats make audits painful and migration nearly impossible. Instrument with OTEL and open conventions like OpenInference so you can change models, vendors, or even observability platforms without rewriting everything.

• Granting broad, environment‑wide access:
  Without space‑level RBAC and clear separation, PHI and non‑PHI traces get mixed. Keep production, sandbox, and partner environments in distinct spaces with least‑privilege access, and enforce SSO/SAML so identities are centrally controlled.

Real-World Example

A European healthcare startup was rolling out a retrieval‑augmented LLM assistant for clinicians—summarizing patient charts, suggesting order sets, and drafting notes. They needed end‑to‑end tracing to understand hallucinations and tool errors but were blocked on two fronts:

• Their legal team required SOC 2 Type II, a HIPAA BAA, and hard EU data residency.
• Their security team insisted on SSO with Okta, space‑level RBAC, and full auditability of who accessed which LLM traces that might contain PHI.

They adopted Arize with EU data region support and a HIPAA BAA. They instrumented their agents using OTEL and OpenInference conventions so each request logged:

• The clinician prompt (with PHI masked in views where necessary).
• RAG retrieval calls against their EU‑hosted patient record index.
• Tool calls to clinical decision support APIs.
• Final LLM responses and downstream EMR updates.

On top of that, they:

• Integrated SSO via Okta with SAML; only a small reliability and safety team got access to PHI‑level spans in the “Prod‑PHI” space.
• Used annotation queues so clinicians could flag bad answers, creating a golden dataset of high‑risk scenarios.
• Configured online evals that caught an uptick in hallucinated medication dosages after a prompt tweak—and blocked the rollout via CI/CD experiments.

When a regulator later audited their AI system, they were able to show:

• SOC2 Type II and HIPAA compliance documentation for Arize.
• The signed BAA.
• Evidence that all access to sensitive traces flowed through SSO with audit logs.
• That all observability data remained in EU infrastructure.

Pro Tip: If you expect PHI or other sensitive data to show up in traces, design your spaces and RBAC model first. Create separate “PHI‑allowed” and “non‑PHI” spaces, wire SSO groups to those spaces, and only then roll out instrumentation—this prevents a messy retrofit later.

Summary

If your search query looks anything like “SOC2 + HIPAA BAA LLM observability platform with SSO/SAML and EU data residency,” what you’re really asking is: “Can I have serious agent observability without losing my compliance posture?” With Arize, you can.

You get:

• SOC2 Type II and HIPAA‑ready observability with support for BAAs.
• SSO/SAML integration and org/space‑level RBAC for strict access control.
• EU (and other region) data residency plus self‑hosting options.
• Open‑standard tracing (OTEL + OpenInference) and evaluation‑driven CI/CD.

That combination lets you ship agents that actually work in production—traced, evaluated, and monitored—without compromising on security or regulatory requirements.

Next Step

Get Started